Displaying drugs 1626 - 1650 of 2773 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Regorafenib | 482.815 C21H15ClF4N4O3 |  | A kinase inhibitor used to treat patients with metastatic colorectal cancer, unresectable, locally advanced, or metastatic gastrointestinal stromal tumors, and hepatocellular carcinoma. | Protein Kinase Inhibitors |
| Aclidinium | 484.651 C26H30NO4S2 |  | An inhaled long-acting anticholinergic used as a maintenance bronchodilator in patients with chronic obstructive pulmonary disease (COPD). | Agents producing tachycardia |
| Enzalutamide | 464.436 C21H16F4N4O2S |  | A second-generation androgen receptor inhibitor used to treat castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer. | Antiandrogens |
| Ponatinib | 532.5595 C29H27F3N6O |  | A kinase inhibitor used to treat patients with various types of chronic myeloid leukemia (CML). | Bcr-Abl Tyrosine Kinase Inhibitors / Protein Kinase Inhibitors |
| Bedaquiline | 555.505 C32H31BrN2O2 |  | A diarylquinoline antimycobacterial used in combination with other antibacterials to treat pulmonary multidrug resistant tuberculosis (MDR-TB). | Diarylquinoline Antimycobacterial |
| Formestane | 302.4079 C19H26O3 |  | For the treatment of estrogen-receptor positive breast cancer in post-menopausal women. | Aromatase Inhibitors |
| Fluticasone furoate | 538.576 C27H29F3O6S |  | An inhaled corticosteroid that can be used as maintenance treatment of asthma and/or chronic obstructive pulmonary disease (COPD) depending on the product. Also available as a nasal spray to manage symptoms of allergic rhinitis. | Glucocorticoids |
| Canagliflozin | 444.516 C24H25FO5S |  | A sodium-glucose co-transporter 2 (SGLT2) inhibitor used to manage hyperglycemia in type 2 diabetes mellitus (DM). Also used to reduce the risk of major cardiovascular events in patients with established cardiovascular disease and type 2 DM. | Glucosides / Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors / Thiophenes |
| Dimethyl fumarate | 144.1253 C6H8O4 |  | A medication used to treat patients with the relapsing-remitting form of multiple sclerosis. | Dermatologicals / Fumarates / Radiation-Sensitizing Agents |
| Glycerol phenylbutyrate | 530.6512 C33H38O6 |  | A nitrogen-binding agent used to manage patients with urea cycle disorders who cannot be sufficiently managed amino acid supplementation and/or dietary restrictions. | Various Alimentary Tract and Metabolism Products |
| Pomalidomide | 273.2441 C13H11N3O4 |  | A thalidomide analogue used in combination with dexamethasone to treat patients with multiple myeloma. | Angiogenesis Inhibitors / Immunologic Factors / Thalidomide Analog |
| Trametinib | 615.3948 C26H23FIN5O4 |  | A kinase inhibitor used alone or in combination with dabrafenib to treat patients with cancers with specific BRAF mutations, such as melanoma and non-small cell lung cancer. | Mitogen-activated protein kinase (MEK) inhibitors / Protein Kinase Inhibitors |
| Dabrafenib | 519.562 C23H20F3N5O2S2 |  | A kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer. | B-Raf serine-threonine kinase (BRAF) inhibitors / Protein Kinase Inhibitors |
| Radium Ra 223 dichloride | 293.924 Cl2Ra |  | A radiopharmaceutical agent used to treat patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastatic disease. | Antineoplastic Agents / Radioactive alpha-Particle Emitting Therapeutic Agent |
| Afatinib | 485.938 C24H25ClFN5O3 |  | An antineoplastic agent used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with non-resistant EGFR mutations or resistance to platinum-based chemotherapy. | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors / Protein Kinase Inhibitors |
| Ferric carboxymaltose | Not Available |  | An iron replacement therapy used to treat iron deficiency anemia in children and adults with intolerance or inadequate clinical response to oral iron, and in adult patients who have non-dialysis dependent chronic kidney disease. | Parenteral Iron Replacement |
| Levomilnacipran | 246.348 C15H22N2O |  | A selective serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat major depressive disorder (MDD) in adults. | Agents producing tachycardia |
| Dolutegravir | 419.3788 C20H19F2N3O5 |  | An antiviral agent used for the treatment of HIV-1 infections in combination with other antiretroviral agents. | HIV Integrase Inhibitors / Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor |
| Riociguat | 422.4157 C20H19FN8O2 |  | A stimulator of soluble guanylate cyclase indicated for the management of persistent or recurrent chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension. | Antihypertensives for Pulmonary Arterial Hypertension |
| Macitentan | 588.273 C19H20Br2N6O4S |  | An endothelin receptor antagonist used to manage pulmonary arterial hypertension to delay disease progression. | Antihypertensives for Pulmonary Arterial Hypertension |
| Luliconazole | 354.27 C14H9Cl2N3S2 |  | A topical antifungal agent used to treat fungal infections. | Imidazole and Triazole Derivatives |
| Sofosbuvir | 529.458 C22H29FN3O9P |  | A direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents. | Antivirals for treatment of HCV infections |
| Chlorcyclizine | 300.826 C18H21ClN2 |  | Chlorcyclizine is a first generation phenylpiperazine class antihistamine used to treat urticaria, rhinitis, pruritus, and other allergy symptoms. Chlorcyclizine also has some local anesthetic, anticholinergic, and antiserotonergic properties, and can... | Piperazine Derivatives |
| Magaldrate | 1115.3 Al5H33Mg10O40S2 |  | An antacid used to treat various conditions in the GI tract, such as esophagitis, duodenal and gastric ulcers, and gastroesophageal reflux. | Antacids With Antiflatulents |
| Isoxsuprine | 301.386 C18H23NO3 |  | A beta-adrenergic agonist used in the symptomatic treatment of cerebrovascular insufficiency, peripheral vascular disease of arteriosclerosis obliterans, thromboangiitis obliterans (Buerger's disease) and Raynaud's disease. | 2-Amino-1-Phenylethanol Derivatives |
Displaying drugs 1626 - 1650 of 2773 in total